Immuron

3 Decision Makers · 3 Verified Contacts & Email Format

📍 Armadale, Victoria, AustraliaPharmaceuticals🗓 Est. 1994👥 Under 10 employees

About Immuron

Immuron focuses on oral immunotherapy using polyclonal antibody products for humans.

Email Format

{first_name}@immuron.com — 100.0%

sarah@immuron.com

Leadership & Decision Makers

Contact details of 3 Immuron decision makers

Steven Lydeamore

CEO
  • Work email

    s****n@immuron.com

Phillip Hains

Company Secretary & CFO

Jerry Kanellos

CEO

General Emails

General company emails, e.g. customer support lines

    info@immuron.com

    General Inquiries

    hello@immuron.com

    General Inquiries

    sales@immuron.com

    Sales Department

    grant@immuron.com

    Unclassified inbox

    amos@immuron.com

    Unclassified inbox

    steve@immuron.com

    Unclassified inbox

    u003esteve@immuron.com

    Unclassified inbox

    officersteve@immuron.com

    Unclassified inbox

Similar Companies like Immuron

Cullinan Oncology

cullinanoncology.com
Pharmaceuticals · Cambridge, MA · Est. 2017 · 11–50 employees

HQ: Cambridge, MA

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Horizon Discovery

horizondiscovery.com
Pharmaceuticals · Cambridge, Cambridgeshire, United Kingdom · Est. 2007 · 101–250 employees

HQ: Cambridge, Cambridgeshire, United Kingdom

Eagle Pharmaceuticals

eagleus.com
Biotechnology · Woodcliff Lake, New Jersey, United States · Est. 2007 · 101–250 employees

HQ: Woodcliff Lake, New Jersey, United States

Ascentage Pharma

ascentagepharma.com
Pharmaceuticals · Suzhou, Jiangsu, China · Est. 2009 · 101–250 employees

HQ: Suzhou, Jiangsu, China

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 29/07/2025

+610398245254

Armadale, Victoria, Australia

Specialization: Biopharmaceutical,
Business Type: Public
Employees: 1-10
Rounds: Grant
Founded Date: 1994
Company Type: For Profit
Stock Symbol: NASDAQ:IMRN
Operating Status: Active
Last Funding Type: Grant
Phone Number: +610398245254
Last Investment Activity: Jul 15, 2024
Investments Activity: Jul 15, 2024 Jul 14, 2024 Jul 3, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.